Medicare Enrolled
Dr. Gopal Krishna, MD
Nephrology · Salinas, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Krishna from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Krishna?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Krishna
Dr. Gopal Krishna is a nephrology specialist in Salinas, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Krishna performed 16,522 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Krishna received a total of $128,281 from 37 pharmaceutical and/or device companies across 733 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Krishna is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 2% volume in CA
$128,281 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗16,522
Medicare services
Top 2% in CA for nephrology
Not available
Unique patients (not deduplicated)
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
7,141 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 3,180 | $17 | $35 |
| Inclisiran injection (Leqvio) for cholesterol | 3,124 | $9 | $22 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
622 | $66 | $105 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
456 | $297 | $480 |
| Hemodialysis, single evaluation A dialysis procedure to filter waste from the blood, performed with a physician's evaluation. |
344 | $60 | $180 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
321 | $53 | $200 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
166 | $8 | $11 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
147 | $12 | $40 |
| Kidney function blood test panel | 132 | $9 | $30 |
| Home dialysis services per month Monthly dialysis treatment provided in the patient's home for individuals aged 20 or older. |
117 | $247 | $480 |
| Dialysis procedure with evaluation A dialysis treatment that includes one evaluation. |
100 | $72 | $180 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
87 | $145 | $271 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
63 | $109 | $200 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
59 | $55 | $250 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
56 | $58 | $150 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
50 | $247 | $480 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
39 | $24 | $100 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
35 | $100 | $145 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
34 | $41 | $60 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
30 | $28 | $28 |
| Red blood cell concentration measurement A laboratory test that measures the concentration of red blood cells in the blood. |
27 | $2 | $30 |
| Hemoglobin blood test A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen. |
27 | $2 | $10 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
27 | $86 | $250 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
25 | $72 | $80 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
25 | $113 | $300 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
24 | $10 | $30 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
23 | $124 | $280 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
16 | $4 | $15 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
14 | $32 | $90 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
11 | $98 | $193 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
43.7% high complexity
45.9% medium
10.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$128,281
Total received (2018-2024)
Avg $18,326/year across 7 years
Top 2% in CA for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
733
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,004
2023
$1,410
2022
$24,079
2021
$14,990
2020
$7,374
2019
$28,540
2018
$45,884
Payments by company (2024)
AKEBIA THERAPEUTICS INC
$2,629
CSL Behring
$2,398
Travere Therapeutics, Inc.
$184
Amgen Inc.
$182
CALLIDITAS THERAPEUTICS US INC.
$136
Ardelyx, Inc.
$126
AstraZeneca Pharmaceuticals LP
$112
Fresenius USA Marketing, Inc.
$97
Otsuka America Pharmaceutical, Inc.
$45
Novo Nordisk Inc
$29
GlaxoSmithKline, LLC.
$24
Novartis Pharmaceuticals Corporation
$22
Bayer Healthcare Pharmaceuticals Inc.
$19
Top 3 companies account for 86.8% of 2024 payments
All-time payments by company (2018-2024) ›
Relypsa, Inc.
$49,039
AstraZeneca Pharmaceuticals LP
$30,027
Vifor Pharma, Inc.
$15,278
Keryx Biopharmaceuticals, Inc.
$8,558
AKEBIA THERAPEUTICS INC
$7,179
Fresenius USA Marketing, Inc.
$7,155
Bayer HealthCare Pharmaceuticals Inc.
$4,141
CSL Behring
$2,398
Amgen Inc.
$963
Janssen Research & Development, LLC
$659
Travere Therapeutics, Inc.
$512
OPKO Pharmaceuticals, LLC
$467
GlaxoSmithKline, LLC.
$264
Otsuka America Pharmaceutical, Inc.
$213
Mallinckrodt Hospital Products Inc.
$181
Abbott Laboratories
$167
CALLIDITAS THERAPEUTICS US INC.
$156
Ardelyx, Inc.
$144
Novartis Pharmaceuticals Corporation
$117
Horizon Therapeutics plc
$113
Aurinia Pharma U.S., Inc.
$91
Daiichi Sankyo Inc.
$72
Calliditas Therapeutics US Inc.
$44
Alexion Pharmaceuticals, Inc.
$42
AMAG Pharmaceuticals, Inc.
$38
Janssen Pharmaceuticals, Inc
$38
Shire North American Group Inc
$35
Novo Nordisk Inc
$29
Horizon Pharma plc
$28
Covidien LP
$26
Bayer Healthcare Pharmaceuticals Inc.
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Kyowa Kirin, Inc.
$16
Genentech USA, Inc.
$15
Hikma Pharmaceuticals USA
$14
Avion Pharmaceuticals
$14
Dova Pharmaceuticals
$13
Top 3 companies account for 73.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AFINITOR · AURYXIA · Aranesp · Auryxia · BENLYSTA · Balcoltra · CARDIOMEMS · CardioMEMS HF System · Dialyzers · Doptelet · ENTRESTO · EVENITY · FARXIGA · FERAHEME · GATTEX · IBSRELA · INJECTAFER · INVOKANA · JARDIANCE · JESDUVROQ · JYNARQUE · KRYSTEXXA · Kerendia · LEQVIO · LOKELMA · LUPKYNIS · Mitigare · NATPARA (PARATHYROID HORMONE) · Ozempic · Palindrome · Parsabiv · Prolia · RAYALDEE · Rayaldee · Rituxan · Soliris · TARPEYO · TAVNEOS · Ultomiris · Vafseo · Velphoro · Veltassa
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Nephrologists in nearby ZIP areas
10
County median income
$94,486
Nearest hospital to ZIP centroid (approximate)
SALINAS VALLEY MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Krishna is a mixed practice specialist, with above-average Medicare volume (top 2% in CA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Krishna experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Krishna performed 7,141 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Krishna receive payments from pharmaceutical companies?
Yes. Dr. Krishna received a total of $128,281 from 37 companies across 733 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Krishna's costs compare to other nephrologists in Salinas?
Dr. Krishna's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Krishna) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Salinas
Browse nephrologists in Salinas ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in CA
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in CA
Which CA nephrologists receive the most from drug and device companies.
By company
Relypsa, Inc. Payments to Doctors
See all physicians who received payments from Relypsa, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Vifor Pharma, Inc. Payments to Doctors
See all physicians who received payments from Vifor Pharma, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology